Gene and Cell Therapy
This page provides educational resources, events, news and products related to gene and cell therapy. Content will cover aspects from the techniques and technologies used, to the increasing numbers of conditions being addressed by these therapies.
Gene and Cell Therapy – Highlights
Five Innovations in Cell-Based Therapy
Download this listicle to learn about recent advances in cell-based therapies including off-the-shelf chimeric antigen receptor (CAR) T-cell therapy, engineered T-cell receptor therapy and mesenchymal stem cell therapies.
Using Immune Cell Metabolism To Build Next-Generation Cell Therapies
Greater appreciation for the complex and dynamic connections between metabolic poise and immune cell function enables researchers to monitor and control how metabolic reprogramming and microenvironmental signals affect the function, fate and fitness of immune cells.
Advances in Cell Therapy
In this article, we review the latest research in cell therapy development, including advances made in the lab that show promise for translation to the clinic, to improvements in developing, testing and manufacturing.
DNA Sequencing in Newborns Reveals Years of Actionable Findings for Infants and Families
Researchers who lead the world’s first comprehensive sequencing program for newborn infants have published the next chapter in the ongoing study of the BabySeq Project, with new findings on infants and families who have been followed for 3-5 years.
Developing Synthetic Affinity Reagents for Improved Diagnostics
To learn more about MIPS and why they are particularly suited for use in in vitro diagnostic assays, we spoke to Dr. Francesco Canfarotta, head of chemistry at MIP Discovery.
A New Gene Therapy To Fight Obesity
A team has designed a strategy to fight obesity and diabetes in mice through ex vivo gene therapy, which consists of implanting cells that have been manipulated and transformed in order to treat a disease.
Why Do Some People Become HIV-Free After Receiving a Stem Cell Transplant?
A study has highlighted how some people may become HIV-free after receiving a stem cell transplant.
Sphere Fluidics Updates Brand Identity To Align With Ambitious, Global Commercial Growth Strategy
Sphere Fluidics announced the introduction of new branding to align with its ambitious global commercial growth strategy.
Cell and Gene Therapy CDMO Targets North American Growth With Major US Acquisition
uBriGene, a cell & gene therapy contract development and manufacturing organization, is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.